Free Trial
NASDAQ:ASRT

Assertio (ASRT) Stock Price, News & Analysis

Assertio logo
$0.64 +0.00 (+0.09%)
Closing price 04:00 PM Eastern
Extended Trading
$0.65 +0.01 (+1.59%)
As of 05:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Assertio Stock (NASDAQ:ASRT)

Key Stats

Today's Range
$0.63
$0.66
50-Day Range
$0.60
$0.71
52-Week Range
$0.51
$1.80
Volume
94,380 shs
Average Volume
575,506 shs
Market Capitalization
$61.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.75
Consensus Rating
Buy

Company Overview

Assertio Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
35th Percentile Overall Score

ASRT MarketRank™: 

Assertio scored higher than 35% of companies evaluated by MarketBeat, and ranked 768th out of 936 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Assertio has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Assertio has only been the subject of 2 research reports in the past 90 days.

  • Read more about Assertio's stock forecast and price target.
  • Earnings Growth

    Earnings for Assertio are expected to grow in the coming year, from ($0.15) to $0.03 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Assertio is -2.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Assertio is -2.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Assertio has a P/B Ratio of 0.51. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Assertio's valuation and earnings.
  • Percentage of Shares Shorted

    6.28% of the float of Assertio has been sold short.
  • Short Interest Ratio / Days to Cover

    Assertio has a short interest ratio ("days to cover") of 18, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Assertio has recently increased by 0.52%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Assertio does not currently pay a dividend.

  • Dividend Growth

    Assertio does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    6.28% of the float of Assertio has been sold short.
  • Short Interest Ratio / Days to Cover

    Assertio has a short interest ratio ("days to cover") of 18, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Assertio has recently increased by 0.52%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Assertio has a news sentiment score of -0.03. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.88 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Assertio this week, compared to 1 article on an average week.
  • Search Interest

    4 people have searched for ASRT on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Assertio insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 4.00% of the stock of Assertio is held by insiders.

  • Percentage Held by Institutions

    48.96% of the stock of Assertio is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Assertio's insider trading history.
Receive ASRT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Assertio and its competitors with MarketBeat's FREE daily newsletter.

ASRT Stock News Headlines

Assertio Holdings, Inc. (ASRT) - Yahoo Finance
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
See More Headlines

ASRT Stock Analysis - Frequently Asked Questions

Assertio's stock was trading at $0.8711 on January 1st, 2025. Since then, ASRT stock has decreased by 26.3% and is now trading at $0.6418.
View the best growth stocks for 2025 here
.

Assertio Holdings, Inc. (NASDAQ:ASRT) posted its earnings results on Monday, May, 12th. The company reported ($0.14) earnings per share for the quarter, missing the consensus estimate of ($0.06) by $0.08. The business earned $26.49 million during the quarter, compared to analyst estimates of $27.52 million. Assertio had a negative net margin of 25.72% and a negative trailing twelve-month return on equity of 24.87%.
Read the conference call transcript
.

Shares of ASRT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Assertio investors own include Plug Power (PLUG), FuelCell Energy (FCEL), Workhorse Group (WKHS), Fortress Biotech (FBIO), KALA BIO (KALA), Lipocine (LPCN) and Ovid Therapeutics (OVID).

Company Calendar

Last Earnings
5/12/2025
Today
7/01/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ASRT
Employees
20
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$2.75
High Stock Price Target
$3.50
Low Stock Price Target
$1.75
Potential Upside/Downside
+328.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$21.58 million
Pretax Margin
-25.59%

Debt

Sales & Book Value

Annual Sales
$119.00 million
Cash Flow
$0.05 per share
Price / Cash Flow
13.22
Book Value
$1.27 per share
Price / Book
0.51

Miscellaneous

Free Float
91,950,000
Market Cap
$61.47 million
Optionable
Optionable
Beta
0.29
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:ASRT) was last updated on 7/1/2025 by MarketBeat.com Staff
From Our Partners